Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Pfizer New Weight Loss Drug & Micron Security Risk In China

    Pfizer New Weight Loss Drug & Micron Security Risk In China

    FromSchwab Network

    Start listeningView podcast show

    Pfizer New Weight Loss Drug & Micron Security Risk In China

    FromSchwab Network

    ratings:
    Length:
    4 minutes
    Released:
    May 22, 2023
    Format:
    Podcast episode

    Description

    Pfizer (PFE) stock price is up today on its weight loss drug that has been proven to be more effective than Ozempic. Will weigh loss occur quicker? Trial participants lost 10 pounds over 16 weeks. The oral drug could offer advantages over frequent injections. Renita Young weighs in on Micron (MU) potentially facing a major security risk and faces a ban of selling chips to some Chinese companies.
    Released:
    May 22, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    A unique lineup of financial news and education programs, all available to stream without a subscription. Listen to industry experts track market action and interpret how it may apply to your investment portfolio. Get real-time insights, commentary, and exclusive access to CEOs, analysts, and market experts. Empowering Every Investor and Trader. Every Market Day. Produced by TD Ameritrade Media Productions Company, a wholly-owned subsidiary of TD Ameritrade Holding Corporation. TD Ameritrade Holding Corporation is a wholly owned subsidiary of The Charles Schwab Corporation. TD Ameritrade Media Productions Company is not a financial adviser, registered investment advisor, or broker-dealer. THE TD AMERITRADE NETWORK SITE, CONTENT, APPS, AND RELATED SERVICES, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS, WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED. This is not an offer or solicitation in any jurisdiction where we are not authorized to do business or where such offer or solicitation would be contrary to the local laws and regulations of that jurisdiction, including, but not limited to persons residing in Australia, Canada, Japan, Saudi Arabia, UK, and the countries of the European Union. All TD Ameritrade Network content © TD Ameritrade Network. All rights reserved.